By pure co-incidence, the re-naming and re-launch of the journal we had come to know as Clinical Risk happens to coincide with the 35th anniversary of the formation of AvMA (Action against Medical Accidentsthe UK charity for patient safety and justice). Back in those days, we were known as 'Action for Victims of Medical Accidents' and started to publish the AVMA Medico-Legal Journal, which was incorporated into Clinical Risk by agreement with the publishers at the time, the Royal Society of Medicine. We are excited by the appointment of Albert Wu as editor-in-chief. Albert is someone we have worked with in the past when we were still campaigning for a statutory Duty of Candour in the UK, and he has a tremendous reputation internationally for his work in patient safety. Clinical Risk has been unique in that it combines a focus on patient safety/risk management with a focus on the medico-legal world, which will continue albeit with more of an international perspective.
In this editorial, I discuss current challenges and opportunities for patient safety and justice that exist in the UK. This is not to say that the Journal will remain focussed narrowly on the UK. It is written in the hope that it will be found interesting whichever part of the world readers are working in, and that it will generate comment, debate, and other contributions from different parts of the globe from which we can also learn.
Somewhat ironically when we at AvMA are still basking in the glory of the statutory Duty of Candour being adopted in England and Scotland (with Wales and Northern Ireland seemingly due to follow), we currently face a potential extraordinary undermining of the whole principle in England. The draft Health Service Safety Investigations Bill 1 currently undergoing scrutiny in England would set up the Health Service Safety Investigations Body (HSSIB) as a totally independent central investigation resource for the NHS, which is to be welcomed. However, it also stipulates that the investigations that HSSIB and the NHS trusts which it accredits would conduct investigations incorporating the so-called 'safe space'. This is supposed to make staff feel more comfortable to take part in investigations without fear of 'unfair' consequences. However, closer analysis of the Bill 2 reveals that in fact all the 'safe space' provision does is 'prohibit disclosure' of information gathered by the investigation. With a few exceptions such as criminal behaviour and imminent threats to patient safety, this prohibition of disclosure applies to everything held by the investigation and disclosure to any person, including the patient whose treatment is being considered (or their family, if deceased).
Obviously, this is quite the opposite of openness and transparency which the Duty of Candour promotes. It would mean that the patient/family would not be able to take full part in investigations or challenge evidence. Not only would this mean poorer investigations but it would also be deeply damaging to the patient/family and public confidence in safety investigations. If patients know that directly relevant evidence is going to be hidden from them, it is highly unlikely they will have confidence in the investigation or those running it. They will be much more likely to turn straightaway to a more adversarial legal challenge than would be the case if they had reason to expect openness from the investigation. It is hard to see what protection this highly controversial measure would provide to NHS staff taking part in investigations. Nearly all the feedback I have had from staff is that the thing they are most fearful of is unfair treatment from their employer or bosses. The measure does nothing to prevent that. Nearly every health professional I have canvassed about this also says that they have no desire to see relevant evidence hidden from patients/families. Indeed, such an approach would be contrary to their own professional codes of conduct.
So what is the real motivation for this? Obviously, only the architects of it can confirm this for sure, but there are clues. The Secretary of State for Health in England has made no secret of his desire to see savings on the massive bill the NHS pays as a result of clinical negligence each year. It would seem that access to justice for injured patient/their families is expendable in that regard. The 'safe space' could be more about saving the Department of Health money by making it harder for patients/families to get the evidence they would need to win a clinical negligence case.
Individual NHS staff are not sued in these instances as the NHS takes corporate vicarious liability.
When looked at alongside another current controversial policy -the imposition of 'fixed recoverable costs' 3,4 in clinical negligence cases, this theory becomes even more plausible. The Department of Health wants to impose an absolute limit on the amount of legal costs that can be recovered by lawyers who represent successful claimants. Examples are given of cases where the legal costs far exceed the amount of damages (compensation) awarded. To someone who does not know much about how these cases are conducted, this may well seem something that needs to stamped down on. No one wants to see 'greedy' lawyers getting fat at the expense of the NHS after all, do they? However, when you understand that significant legal costs only arise at all if the case is (unsuccessfully) defended, and that very high legal costs are almost always a result of protracted and sometimes completely unreasonable denials and delays by the defence side, it tells a different story.
The simple fact is that NHS lawyers would be able to deny and defend in the knowledge that the patient/ family will not be able to find a lawyer to take on their case, because they could never recover their real costs let alone make a profit. Whether intended or not, this could leave some of the most needy and deserving in society unable to get justice. It will also mean that NHS will fail to learn important lessons about mistakes made and how to improve patient safety. At the time of writing (December 2017) the Department of Health had not yet declared their final position on 'fixed costs' but we were expecting a statement imminently.
The draft Health Service Safety Investigations Bill is due to be scrutinised by a select committee in 2018 before following the usual parliamentary process for a bill. AvMA and others who are passionate about patient safety and justice will be doing their very best to influence these policies for the better. It goes to show that for all that AvMA and the NHS has achieved in the last 35 years, AvMA is as needed now as it ever was! On a more positive note, one of AvMA's most successful campaigns -for the legal Duty of Candourcontinues. It resulted in the introduction of a statutory duty on all providers of health and social care in England at the end of 2014. In spite of no central training programme and also a rather low key approach to enforcement by the regulator, the Care Quality Commission (CQC), feedback suggests that it is already making a difference. Many more people are being told about incidents than before. Staff report that they feel empowered by being able to remind colleagues who do not want to tell patients/families the whole truth about incidents that they have to tell, by law. Certainly, we would like to see more training and support for staff in delivering the Duty of Candour well and we would like to see the CQC be seen to take robust action against organisations who fail to comply. Even the wording of the regulations could do with a tidy up. However, we are in a far better place with it than without it. Scotland implements its Duty of Candour in April 2018 and Wales and Northern Ireland seem set to follow.
It would be interesting to hear to what extent other countries are debating similar issues, or have experience of dealing with them.
